Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of huperzine a powder in China. Welcome to wholesale bulk high quality huperzine a powder for sale here from our factory. Good service and reasonable price are available.
Huperzine A Powder (Huperzine A) is a natural alkaloid extracted from the Taxaceae plant Melastomataceae, belonging to the class of potent, highly selective, and reversible acetylcholinesterase (AChE) inhibitors. It has been used to treat inflammation, fever, and cognitive impairment. Modern research has confirmed that it has significant neuroprotective effects and has become an important drug for treating neurodegenerative diseases such as Alzheimer's disease.
The appearance is a slightly yellow to white crystalline powder, easily soluble in chloroform, methanol, ethanol, and slightly soluble in water. It is rapidly and completely absorbed orally, with a bioavailability of up to 96.6%. It easily penetrates the blood-brain barrier and is widely distributed in the brain, mainly in the frontal lobe, temporal lobe, hippocampus, and other brain areas closely related to learning and memory.
|
|
|
Huperzine A COA
It effectively inhibits the activity of acetylcholinesterase in the human brain, prevents the rapid breakdown and degradation of acetylcholine (ACh) in nerve tissues, thereby significantly elevating the concentration of ACh within the synaptic cleft and further strengthening cholinergic neurotransmission efficiency in the central nervous system. In addition to its core cholinergic regulation, it also exerts prominent neuroprotective effects through modulating NMDA receptor activity and enhancing endogenous antioxidant capacity, alleviating neuronal oxidative stress and inflammatory damage.
Clinically, it can remarkably improve cognitive function, learning and memory ability, as well as daily living self-care capacity in patients diagnosed with mild to moderate Alzheimer's disease.Multiple pharmacological and clinical studies have confirmed that its overall therapeutic efficacy is obviously superior to traditional mainstream drugs such as donepezil. Moreover, it can also assist in ameliorating cerebral microcirculation, boosting cerebral blood perfusion, and promoting neuronal repair and neuroplasticity, achieving multi-pathway intervention on disease progression. Huperzine A Powder is a precious natural alkaloid efficiently extracted and refined from the Cryptomeriaceae plant *Taxodium erinaceus*.
It possesses the pharmacological characteristics of potent activity, high target selectivity and reversible inhibition against acetylcholinesterase (AChE). With in-depth research on its pharmacological mechanism and clinical value in recent years, It has gained extensive academic and industrial attention, showing broad application prospects in the fields of neurodegenerative disease intervention, age-related cognitive impairment improvement, adjuvant treatment of myasthenia gravis, and brain health maintenance. The following is a detailed explanation of its main pharmacological effects and practical application purposes:
Application Of it In Neurodegenerative Diseases
Alzheimer's disease
This compound effectively inhibits the activity of acetylcholinesterase (AChE) in the central nervous system, preventing the rapid metabolic breakdown of acetylcholine (ACh) at nerve junctions, thereby markedly raising the concentration of ACh within the synaptic cleft and effectively enhancing the efficiency of cholinergic neurotransmission. In addition to its cholinesterase inhibitory effect, huperzine A can exert obvious neuroprotective effects by modulating the function of NMDA receptors and elevating endogenous antioxidant activity, reducing neuronal oxidative damage and excitotoxicity. Multiple clinical trials and pharmacological studies have confirmed.
Vascular dementia&Parkinson's disease
Huperzine A may alleviate cognitive impairment in patients with vascular dementia by improving cerebral blood flow and neuroplasticity. A study on patients with vascular dementia showed that huperzine A can significantly improve their cognitive function and daily living ability. Although research on huperzine A in Parkinson's disease is relatively limited, some preliminary studies suggest that it may improve motor symptoms in Parkinson's disease patients.
Application In Myasthenia Gravis
This enhances the transmission of neuromuscular junctions and improves muscle weakness symptoms by inhibiting the activity of AChE and increasing the concentration of ACh in synaptic cleft. A study on patients with myasthenia gravis showed that Huperzine A has an effective rate of 99% and can significantly improve muscle strength and motor function in patients. Another study showed that Huperzine A has a longer duration of action and fewer side effects compared to traditional acetylcholinesterase drugs such as neostigmine. The advantage of it in the treatment of myasthenia gravis lies in its potent and reversible AChE inhibitory effect, with fewer side effects on the central nervous system.
Benign Memory and Cognitive Impairment Associated with Schizophrenia
Huperzine A improves memory and learning function by enhancing cholinergic neurotransmission. Multiple studies have shown that Huperzine A can improve the directional memory, associative learning, image recall, meaningless graphic recognition, and portrait recall abilities of patients with benign memory impairment. Suitable for middle-aged and elderly people with memory impairment caused by aging or mild brain injury. Huperzine A may improve cognitive function in patients with schizophrenia by regulating the balance of the dopaminergic and cholinergic systems. Some studies have shown that Huperzine A has a significant improvement effect.
Applications In Other Fields
Neuroprotective&Antidepressant Effects&Improving Sleep Quality-Huperzine A can protect neurons from damage through its antioxidant, anti-inflammatory, and anti apoptotic effects. Animal experiments have shown that Huperzine A can alleviate neuronal damage caused by cerebral ischemia, traumatic brain injury, and neurodegenerative diseases. Some preliminary studies suggest that Huperzine A may improve depressive symptoms by regulating the levels of monoamine neurotransmitters such as serotonin and dopamine. Huperzine A may indirectly improve sleep quality by regulating the cholinergic system and improving cognitive function.
Fluorescent labeling experiment of Huperzine A in enhancing dynamic connectivity of neuronal mitochondrial networks
Mitochondria, as the "energy factory" of cells, not only play a core role in energy metabolism in neurons, but also participate in key physiological processes such as cell signaling, calcium homeostasis regulation, and apoptosis regulation. Research has shown that neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease are often accompanied by mitochondrial dysfunction and abnormal dynamic connectivity, leading to energy metabolism disorders, increased oxidative stress, and neuronal apoptosis. Huperzine A Powder is a natural alkaloid extracted from plants in the family Taxaceae, which exhibits potent and highly selective acetylcholinesterase (AChE) inhibition.
The use of fluorescence labeling technology to study the effect of Huperzine A on the dynamic connectivity of neuronal mitochondrial networks is of great significance for revealing its neuroprotective mechanism-The neuroprotective effect and mitochondrial function of Huperzine A.The neuroprotective effect of Huperzine A:This enhances cholinergic neurotransmission and improves cognitive function by inhibiting AChE activity and increasing the concentration of acetylcholine (ACh) in synaptic cleft. In addition, Huperzine A also has antioxidant, anti-inflammatory, and anti apoptotic effects, which can alleviate neuronal damage.
Mitochondrial function and neurodegenerative diseases-Mitochondrial dysfunction is one of the important pathological features of neurodegenerative diseases. Abnormal mitochondrial dynamic connectivity can lead to abnormal mitochondrial morphology, energy metabolism disorders, and increased oxidative stress, thereby triggering neuronal apoptosis;The relationship between Huperzine A and mitochondrial function-Research has shown that this can alleviate neuronal mitochondrial damage induced by β - amyloid (A β), hydrogen peroxide, etc., protect mitochondrial membrane potential, and reduce cell apoptosis. In addition, it may also affect mitochondrial dynamic connectivity.
Application of Fluorescence Labeling Technology in the Study of Neuronal Mitochondria
Fluorescence labeling technology combines fluorescent proteins or dyes with target molecules (such as mitochondria) and observes the dynamic behavior of the target molecules using a fluorescence microscope. Common mitochondrial fluorescent markers include:Fluorescent proteins such as mito GFP and mito RFP are expressed in mitochondria through gene transfection techniques.Fluorescent dyes, such as MitoTracker, can specifically bind to mitochondrial membrane potential and are suitable for live cell imaging.
Observation of mitochondrial morphology and distribution: Through fluorescent labeling, the morphology (such as tubular or granular) and distribution characteristics of mitochondria in neurons can be visually observed.Mitochondrial trajectory tracking: Combined with time series imaging technology, it can record the transport trajectory and velocity of mitochondria in neuronal axons and dendrites.Mitochondrial fusion and fission event detection: Through high-resolution imaging technology, the dynamic process of mitochondrial fusion and fission can be observed, and the fusion and fission frequency can be quantitatively analyzed.
Experimental design on the influence of dynamic connections in neuronal mitochondrial networks
01.Experimental Materials:
Cell model: Primary cultured rat hippocampal neurons or human neuroblastoma cell lines (such as SH-SY5Y).
Fluorescent markers: Mito GFP (gene transfection) or MitoTracker Red (fluorescent dye).
Drug: HuperzineA (with different concentration gradients).
Instruments: Confocal microscope, super-resolution microscope, cell culture incubator, etc.
02.Experimental Method:
Neurons are seeded in confocal culture dishes and cultured for a specific period of time before transfection with mito GFP plasmid or addition of MitoTracker Red dye.
Neurons were divided into a control group and a Huperzine A treatment group (at different concentrations), and imaging was performed after a specific treatment time.
Using confocal microscopy or super-resolution microscopy to perform time-series imaging of neurons and record the dynamic behavior of mitochondria.
Mitochondrial morphology analysis: Calculate the length, number of branches, and morphology index of mitochondria.
Mitochondrial motion trajectory analysis: Track the motion trajectory of mitochondria, calculate average velocity and displacement.
03.Expected Experimental Results:
Mitochondrial morphology and distribution
After treatment with Huperzine A, the morphology of neuronal mitochondria may become more regular and evenly distributed.
Mitochondrial motility
Huperzine A may enhance the transport capacity of mitochondria in neuronal axons and dendrites, and improve the dynamic connectivity of mitochondria.
Mitochondrial fusion and division
Huperzine A Powder may regulate the expression of mitochondrial fusion and division related proteins, promote mitochondrial fusion.
FAQ
Huperzine A functions by inhibiting acetylcholinesterase and elevating acetylcholine levels within the central nervous system. Due to its cholinergic regulatory mechanism, it may produce additive physiological effects when combined with other cognitive or cholinergic drugs. Such interaction could amplify unwanted bodily responses and affect overall neurological stability, requiring cautious use alongside prescription neurological treatments.
Beyond clinical research trials for neurological disorders, Huperzine A is also marketed as an over-the-counter food supplement with recommended daily dosages set higher than those used in most medical studies.
Reported adverse reactions of this powder are closely linked to the administered dosage and individual physical tolerance. Higher intake levels far above clinical experimental doses tend to raise the probability of digestive discomfort and mild neural overexcitation. Most adverse symptoms observed in research trials remain mild and appear more frequently when supplementation exceeds standard experimental dosages.
Huperzine A has been investigated as a treatment for neurological conditions such as Alzheimer's disease.
Huperzine A is under investigation for use as a drug for Alzheimer's disease. Adverse effects like diarrhoea, nausea and vomiting have been reported in these studies, where the investigated doses generally are half the highest dose recommended by vendors of food supplements.
Hot Tags: huperzine a powder, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, API Researching Only , epinephrine powder, larocaine hydrochloride, levamisole hydrochloride powder, Medetomidine hydrochloride, tetramisole hcl powder